Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacidipine Long-term Safety Follow-up in Hypertension
NCT02177331Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 1995
- Primary completion
- Jan 1998
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lacidipine in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Jun 1995; status: completed.
02
Drugs
lacidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02177331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177331.